Spots Global Cancer Trial Database for radiotherpay
Every month we try and update this database with for radiotherpay cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Phase III RCT of Radiotherapy Plus Toripalimab Versus Sorafenib in Advanced Hepatocellular Carcinoma With PVTT | NCT04709380 | Radiotherapy Toripalimab Sorafenib Advanced Hepato... | Radiotherapy pl... Sorafenib | 18 Years - 80 Years | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | |
Phase III RCT of Radiotherapy Plus Toripalimab Versus Sorafenib in Advanced Hepatocellular Carcinoma With PVTT | NCT04709380 | Radiotherapy Toripalimab Sorafenib Advanced Hepato... | Radiotherapy pl... Sorafenib | 18 Years - 80 Years | Cancer Institute and Hospital, Chinese Academy of Medical Sciences |